Live feed
Filing
SC 13G
SC 13G0001193805-14-001592·Flynn James E
Schedule 13G ownership disclosure
Vanda Pharmaceuticals Inc
Security class unavailable · CUSIP: 921659108
Event date: 2014-07-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-14-001592
- Form type
- SC 13G
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Aug 01, 2014
- Reporting period
- Jul 23, 2014
- Description
- Schedule 13G beneficial ownership